HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Kohgo Selected Research

Diphyllobothriasis

8/2010Capsule endoscopy is a feasible procedure for identifying a Diphyllobothrium nihonkaiense infection and determining the indications for vermifuge treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Kohgo Research Topics

Disease

31Neoplasms (Cancer)
01/2019 - 07/2002
15Iron Overload
03/2017 - 08/2002
11Hepatocellular Carcinoma (Hepatoma)
09/2022 - 04/2002
11Inflammation (Inflammations)
09/2020 - 09/2002
10Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2004
8Stomach Neoplasms (Stomach Cancer)
12/2020 - 07/2002
8Fibrosis (Cirrhosis)
05/2018 - 08/2003
8Non-alcoholic Fatty Liver Disease
03/2017 - 03/2008
7Colitis
08/2015 - 04/2004
6Carcinogenesis
01/2019 - 04/2008
6Liver Diseases (Liver Disease)
05/2018 - 04/2002
6Infections
11/2017 - 11/2006
6Colonic Neoplasms (Colon Cancer)
01/2017 - 09/2005
6Anemia
01/2015 - 10/2002
6Crohn Disease (Crohn's Disease)
01/2013 - 12/2005
6Alcoholic Liver Diseases (Alcoholic Liver Disease)
03/2008 - 08/2002
5Fatty Liver
03/2017 - 10/2005
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2012 - 12/2005
4Hemorrhage
01/2022 - 10/2011
4Colorectal Neoplasms (Colorectal Cancer)
11/2015 - 08/2002
4Hypoxia (Hypoxemia)
04/2012 - 09/2005
4Leukemia
01/2010 - 11/2005
4Chronic Hepatitis C
09/2009 - 06/2004
3Liver Cirrhosis (Hepatic Cirrhosis)
05/2018 - 11/2011
3Neoplasms, Cystic, Mucinous, and Serous
01/2018 - 01/2007
3Obesity
02/2013 - 09/2007
3Metaplasia
05/2012 - 02/2006
3Lymphoma (Lymphomas)
07/2011 - 07/2008
3Chromosome Aberrations (Chromosome Abnormalities)
03/2011 - 11/2005
3Adenocarcinoma
12/2010 - 01/2004
2Disease Progression
12/2020 - 06/2014
2Breast Neoplasms (Breast Cancer)
01/2019 - 07/2008
2Hypoalbuminemia
05/2018 - 01/2011
2Edema (Dropsy)
05/2018 - 01/2011
2Hemochromatosis (Bronze Diabetes)
03/2017 - 11/2009
2Ulcerative Colitis
12/2015 - 04/2011
2Wounds and Injuries (Trauma)
07/2015 - 04/2013
2Multiple Myeloma
07/2015 - 10/2006
2Enteritis
07/2015 - 01/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2015 - 11/2006
2Aplastic Anemia (Anemia, Hypoplastic)
01/2015 - 11/2006
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2014 - 05/2007
2Acute Promyelocytic Leukemia
06/2014 - 01/2012
2Disseminated Intravascular Coagulation
01/2014 - 01/2012
2Carcinoma (Carcinomatosis)
09/2013 - 02/2006

Drug/Important Bio-Agent (IBA)

28IronIBA
09/2022 - 08/2002
14Messenger RNA (mRNA)IBA
01/2019 - 07/2002
9HepcidinsIBA
01/2019 - 11/2005
8Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2008
8Proteins (Proteins, Gene)FDA Link
07/2015 - 07/2002
7CytokinesIBA
08/2014 - 09/2002
7PPAR gammaIBA
06/2006 - 07/2002
6Transferrin Receptors (Transferrin Receptor)IBA
03/2017 - 08/2002
5Indicators and Reagents (Reagents)IBA
05/2018 - 05/2011
5Ferritins (Ferritin)IBA
03/2017 - 10/2002
5Monoclonal AntibodiesIBA
05/2012 - 02/2006
5MucinsIBA
10/2011 - 01/2003
5LigandsIBA
01/2010 - 07/2002
5Troglitazone (Rezulin)FDA Link
06/2005 - 07/2002
4Dextrans (Dextran)FDA Link
08/2015 - 11/2011
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
08/2015 - 11/2011
4Infliximab (Remicade)FDA Link
01/2013 - 12/2005
4LipidsIBA
11/2012 - 10/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2011 - 09/2005
4GemcitabineFDA Link
10/2009 - 03/2004
3Chelating AgentsIBA
09/2022 - 11/2011
3DeferasiroxFDA Link
09/2022 - 11/2011
3CollagenIBA
08/2015 - 08/2003
3Pharmaceutical PreparationsIBA
06/2014 - 11/2006
3Cadherins (E-Cadherin)IBA
09/2013 - 01/2004
3Alanine Transaminase (SGPT)IBA
09/2013 - 06/2004
3SteroidsIBA
04/2011 - 10/2005
3Dextran SulfateIBA
01/2011 - 04/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 07/2007
3Peptides (Polypeptides)IBA
01/2010 - 08/2003
3p38 Mitogen-Activated Protein KinasesIBA
09/2005 - 03/2004
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
10/2021 - 12/2020
2Proton Pump InhibitorsIBA
10/2021 - 12/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2020 - 01/2013
2Branched-Chain Amino AcidsIBA
05/2018 - 06/2014
2MicroRNAs (MicroRNA)IBA
01/2018 - 06/2013
2RNA (Ribonucleic Acid)IBA
03/2017 - 11/2015
212,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA
01/2017 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
07/2016 - 04/2010
2PolyphosphatesIBA
02/2016 - 08/2015
2Heterogeneous Nuclear Ribonucleoprotein A1IBA
11/2015 - 07/2015
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2015 - 06/2013
2Small Interfering RNA (siRNA)IBA
07/2015 - 06/2013
2AntibodiesIBA
07/2015 - 07/2008
2Toll-Like Receptors (Toll-Like Receptor)IBA
08/2014 - 01/2013
2Fatty Acids (Saturated Fatty Acids)IBA
08/2014 - 09/2007
2InterferonsIBA
02/2014 - 10/2005
2Dacarbazine (DIC)FDA LinkGeneric
01/2014 - 01/2012
2ThrombomodulinIBA
01/2014 - 01/2012
2Imatinib Mesylate (Gleevec)FDA Link
09/2013 - 11/2005

Therapy/Procedure

22Therapeutics
09/2020 - 03/2004
8Drug Therapy (Chemotherapy)
09/2022 - 08/2002
3Stem Cell Transplantation
06/2014 - 11/2006
2Chelation Therapy (Therapy, Chelation)
03/2017 - 01/2015
2Appendectomy
10/2013 - 10/2011